What is HEM Pharma Inc.'s (376270.KQ) StockRank?

MoatMap's StockRank for HEM Pharma Inc. (376270.KQ) is 3/100, with a Strong Sell signal. This is a composite score combining Quality (14), Value (32), and Momentum (32) factor ranks across MoatMap's 20,000+ stock universe.

Does HEM Pharma Inc. have an economic moat?

HEM Pharma Inc. (376270.KQ) has a Quality factor score of 14/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is HEM Pharma Inc. a buy, hold, or sell?

MoatMap's current signal for HEM Pharma Inc. (376270.KQ) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is HEM Pharma Inc. in?

HEM Pharma Inc. (376270.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

376270.KQ

STRONG SELL

HEM Pharma Inc. · Healthcare · South Korea · $203M · Avg Vol: $1M/d

StockRank

P/E (TTM)

—

ROE

-194.4%

D/E

11.2x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

COMPANY DESCRIPTION

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	2M	4M	10M	9M	52.4%
EPS	-1.48	-1.28	-0.79	-2.23	—
Shares	7M	7M	7M	7M	+1.7%
Debt	8M	5M	5M	13M	15.0%
Equity	13M	11M	17M	3M	-37.3%
Op CF	-7M	-3M	-5M	-5M	—
Inv CF	-11M	8M	-6M	-4M	—
Fin CF	13M	-667,330	10M	14M	—

PRICE (1M)-15.8%

SMA 50SMA 200

$33.24

RSI (14)

49.8

52W High

$64.18

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

-203.3%1.9

ROE

-194.4%3.7

GP/Assets

0.5%11.6

Op. Margin

-77.8%18.4

FCF/Assets

9.7%86.5

Piotroski

—7.2

Int. Cover

-35.5x15.1

D/E Ratio

11.21x0.8

Current Ratio

0.48x2.2

Value

P/E (TTM)

—N/A

EV/EBITDA

-21.8x87.7

P/FCF

93424.9x18.0

P/B

60.2x1.2

P/S

21.4x16.5

Div Yield

—N/A

Momentum

52W High %

52%26.2

RS 6M

-119%7.5

SMA 50/200

1.13x84.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$203M

P/E (Forward)

—

Gross Margin

1.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 376270.KQ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
376270.KQ	HEM Pharma Inc.(you)	$203M	3	STRONG SELL
287840.KQ	IntoCell, Inc.	$227M	2	STRONG SELL
493280.KQ	IMBiologics	$259M	2	STRONG SELL
424870.KQ	ImmuneOncia	$252M	1	STRONG SELL
468530.KQ	PROTEINA	$261M	1	STRONG SELL
228760.KQ	Genomictree Inc.	$216M	9	STRONG SELL
304360.KQ	S.Biomedics Co., Ltd.	$225M	9	STRONG SELL
338840.KQ	Y-Biologics	$136M	3	STRONG SELL
394800.KQ	3billion	$154M	6	STRONG SELL
372320.KQ	Curocell	$285M	1	STRONG SELL

Peer medians: ROE -1.1% · P/E 17.7x · Gross margin 43.6%

HEM Pharma Inc. (376270.KQ) — Stock Score Summary

HEM Pharma Inc. (376270.KQ) has a MoatMap StockRank of 3/100 based on Quality (14/100), Value (32/100), and Momentum (32/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price	$33.24
Market Cap	$203M
Price/Book	60.25
Return on Equity	-194.4%
Return on Invested Capital	-203.3%
Debt/Equity	1121.24
Gross Margin	1.9%
Operating Margin	-77.8%
Revenue Growth	40.8%
Free Cash Flow	$2K

HEM Pharma Inc. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is HEM Pharma Inc.’s (376270.KQ) StockRank?: MoatMap’s StockRank for HEM Pharma Inc. (376270.KQ) is 3/100, with a Strong Sell signal. It is a composite of Quality (14), Value (32), and Momentum (32) factor ranks across MoatMap’s 20,000+ stock universe.
Does HEM Pharma Inc. have an economic moat?: HEM Pharma Inc. (376270.KQ) has a Quality factor score of 14/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is HEM Pharma Inc. a buy, hold, or sell?: MoatMap’s current signal for HEM Pharma Inc. (376270.KQ) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is HEM Pharma Inc. in?: HEM Pharma Inc. (376270.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).